semaglutide and ocd Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry 12-month neurological and psychiatric outcomes

Increased Risk of Nausea, Dehydration, and Blood Sugar Drops Nausea is one of the most common side effects during the first weeks of semaglutide therapy, affecting up to 30% of users

Do perimenopause periods have you scratching your head

GLP-1 receptor agonists have demonstrated cardiovascular benefits with some injectable agents

Available in English and Spanish, our content summarizes available scientific information on whether people and their developing babies are at risk because of an exposure in their environment

If you are in the early weeks of your starting dose , be especially cautious with early dosing since your body has not yet adapted to the medication

Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction